Interní Med. 2018; 20(3): 118-120 | DOI: 10.36290/int.2018.022

Chronic pulmonary disease and metabolic syndrome

MUDr. Milan Sova, Ph.D.
Klinika plicních nemocí a tuberkulózy, Fakultní nemocnice Olomouc a Lékařská fakulta Univerzity Palackého v Olomouci

This review is focused on chronic obstructive pulmonary disease and metabolic syndrome; mainly on new findings in this field ofresearch and on common risk factors and mechanisms mutually influencing both metabolic syndrome and chronic obstructivepulmonary disease.

Keywords: chronic pulmonary disease, metabolic syndrome, diabetes mellitus

Published: July 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sova M. Chronic pulmonary disease and metabolic syndrome. Interní Med. 2018;20(3):118-120. doi: 10.36290/int.2018.022.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: 442. Go to original source...
    2. Cebron Lipovec N, Beijers RJ, van den Borst B, et al. The prevalence of Metabolic Syndrome in Chronic Obstructive Pulmonary Disease: A systematic Review. COPD 2016; 13: 399-406. Go to original source... Go to PubMed...
    3. Mannino DM, Thorn D, Swensen A, et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32: 962-969. Go to original source... Go to PubMed...
    4. Bhatt SP, Dransfield MT. Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res 2013; 162: 237-251. Go to original source... Go to PubMed...
    5. Kuller LH, Ockene JK, Townsend M, et al. The epidemiology of pulmonary function and COPD mortality in the multiple risk factor intervention trial. Am Rev Respir Dis 1989; 140: S76-S81. Go to original source... Go to PubMed...
    6. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752. Go to original source... Go to PubMed...
    7. Hu G, Qiao Q, Tuomilehto J, et al.Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascuar mortality in nondiabetic European men and women. Arch Intern Med 2004; 164: 1066-1076. Go to original source... Go to PubMed...
    8. Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and bodymass index: United States, 2003-2006. Natl Health Stat Rept 2009; 13: 1-7.
    9. Svobodova S, Topolcan O. Metabolický syndrom, predikce a prevence. Interní Med. 2012; 14: 412-414.
    10. Marquis K, Maltais F, Duguay V, et al. The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2005; 25: 226-232. Go to original source... Go to PubMed...
    11. Watz H, Waschki B, Kirsten A, et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest 2009; 136: 1039-1046. Go to original source... Go to PubMed...
    12. Clini E, Crisafulli E, Radaeli A, et al. COPD and the metabolic syndrome: an intriguing association. Intern Emerg Med. 2013; 8: 283-289. Go to original source... Go to PubMed...
    13. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716. Go to original source... Go to PubMed...
    14. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-1757. Go to original source... Go to PubMed...
    15. Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163: 427-436. Go to original source... Go to PubMed...
    16. Koblížek V, Chlumský J, Zindr V, et al. Doporučený postup ČPFS pro diagnostiku a léčbu stabilní CHOPN. Dostupné 8. 1. 2017 na http://www.pneumologie.cz/upload/1480193834.pdf
    17. Egbuonu F, Antonio FA, Edavalath M. Effect of inhaled corticosteroids on glycemic status. Open Respir Med J. 2014; 8: 101-105 Go to original source... Go to PubMed...
    18. Suissa S, Kezouh A, Ernst P. Inhaled corticosteroids and the risks of diabetes onset and progression. Am J Med 2010; 123: 1001-1006. Go to original source... Go to PubMed...
    19. Mirrakhimov AE. Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony. Cardiovasc Diabetol 2012; 11: 132. Go to original source... Go to PubMed...
    20. Kiviranta K, Turpeinen M. Effect of eight months of inhaled beclomethasone dipropionate and budesonide on carbohydrate metabolism in adults with asthma. Thorax 1993; 48: 974-978. Go to original source... Go to PubMed...
    21. Saag KG, Furst DE. Major side effects of systemic glucocorticoids. Dostupné 8. 1. 2018 na http://www.uptodate.com
    22. Diez-Manglano J, Barquero-Romero J, Almagro P, et al. COPD patients with and without metabolic syndrome: clinical and functional differences. Intern EmergMed 2014; 9: 419-425. Go to original source... Go to PubMed...
    23. Chinn DJ, Cotes JE, Reed JW. Longitudinal effects of change in body mass on measurements of ventilatory capacity. Thorax 1996; 51: 699-704. Go to original source... Go to PubMed...
    24. Guerra S, Sherrill DL, Bobadilla A, et al. The relation of body mass index to asthma, chronic bronchitis, and emphysema. Chest 2002; 122: 1256-1263. Go to original source... Go to PubMed...
    25. Paek YJ, Jung KS, Hwang YI, et al. Association between low pulmonary function and metabolic risk factors in Korean adults: the Korean National Health and Nutrition Survey. Metabolism 2010; 59: 1300-1306. Go to original source... Go to PubMed...
    26. Franssen FME, O'Donnell DE, Goossens GH, et al. Obesity and the lung: 5. Obesity and COPD. Thorax 2008; 63: 1110-1117. Go to original source... Go to PubMed...
    27. Koehler F,Doehner W,Hoernig S, et al. Anorexia in chronic obstructive pulmonary disease: association to cachexia and hormonal derangement. Int J Cardiol 2007; 119: 83-89. Go to original source... Go to PubMed...
    28. Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006; 173: 79-83. Go to original source... Go to PubMed...
    29. Curtis JP, Selter JG, Wang Y, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005; 165: 55-61. Go to original source... Go to PubMed...
    30. Agusti A, Thomas A. Neff lecture: chronic obstructive pulmonary disease-a systemic disease. Proc Am Thorac Soc 2006; 3: 478-481. Go to original source... Go to PubMed...
    31. Barnes PJ, Celli B. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33: 1165-1185. Go to original source... Go to PubMed...
    32. Tkacova R. Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Rev Lit Future Perspect Mediat Inflamm 2010: 585989 Go to original source... Go to PubMed...
    33. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-355 Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.